News
The Tovino Thomas starrer has been mounted at a budget of 10 crores. With its current India net collection of 13.23 crores, ...
Those following along with Atome Plc ( LON:ATOM ) will no doubt be intrigued by the recent purchase of shares by ...
PTY's DRIP program and tactical share issuance add value for long-term holders. Click here to read why PTY CEF is rated as a ...
Section 1.10.32 of "de Finibus Bonorum et Malorum", written by Cicero in 45 BC ...
Many Carnival Corporation & plc (NYSE:CCL) insiders ditched their stock over the past year, which may be of interest to the company's shareholders. When analyzing insider transactions, it is usually ...
What type of skillset does Drake transfer forward Joey Matteoni bring to Iowa men's basketball? Here is some insight for Hawkeyes fans.
16h
MedPage Today on MSNAlternative Endpoints in Phase III Trials Don't Always Mean Boosts to OS, QOLThe findings suggest that "the heightened focus on alternative endpoints, now representing the most common primary endpoint, ...
The Indian Institute of Technology (IIT) Kanpur has officially announced the much-awaited Joint Entrance Examination ...
Discover 8 free open-source Android apps that prioritize privacy, functionality, and transparency. Enhance your experience ...
All patients in the treatment arm remain disease-free after a minimum of 2-year follow-up in the randomized Phase I trial in resected HPV-n ...
AstraZeneca Says Camizestrant Reduces Risk Of Disease Progression By 56% In SERENA-6 Phase III Trial
(RTTNews) - AstraZeneca PLC (AZN) announced positive results from the SERENA-6 Phase III trial, demonstrating that camizestrant, in combination with a cyclin-dependent kinase (CDK) 4/6 inhibitor, sign ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results